Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study
- PMID: 16626503
- PMCID: PMC1550870
- DOI: 10.1186/cc4902
Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study
Abstract
Introduction: The aim of this study was to elucidate the impact of intensive care unit (ICU)-acquired infection on hospital mortality.
Methods: Patients with a longer than 48 hour stay in a mixed 10 bed ICU in a tertiary-level teaching hospital were prospectively enrolled between May 2002 and June 2003. Risk factors for hospital mortality were analyzed with a logistic regression model.
Results: Of 335 patients, 80 developed ICU-acquired infection. Among the patients with ICU-acquired infections, hospital mortality was always higher, regardless of whether or not the patients had had infection on admission (infection on admission group (IAG), 35.6% versus 17%, p = 0.008; and no-IAG, 25.7% versus 6.1%, p = 0.023). In IAG (n = 251), hospital stay was also longer in the presence of ICU-acquired infection (median 31 versus 16 days, p < 0.001), whereas in no-IAG (n = 84), hospital stay was almost identical with and without the presence of ICU-acquired infection (18 versus 17 days). In univariate analysis, the significant risk factors for hospital mortality were: Acute Physiology and Chronic Health Evaluation (APACHE) II score >20, sequential organ failure assessment (SOFA) score >8, ICU-acquired infection, age > or = 65, community-acquired pneumonia, malignancy or immunosuppressive medication, and ICU length of stay >5 days. In multivariate logistic regression analysis, ICU-acquired infection remained an independent risk factor for hospital mortality after adjustment for APACHE II score and age (odds ratio (OR) 4.0 (95% confidence interval (CI): 2.0-7.9)) and SOFA score and age (OR 2.7 (95% CI: 2.9-7.6)).
Conclusion: ICU-acquired infection was an independent risk factor for hospital mortality even after adjustment for the APACHE II or SOFA scores and age.
Similar articles
-
[Analysis of death risk factors for nosocomial infection patients in an ICU: a retrospective review of 864 patients from 2009 to 2015].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Aug;28(8):704-8. doi: 10.3760/cma.j.issn.2095-4352.2016.08.007. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016. PMID: 27434560 Chinese.
-
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.Chest. 1999 Feb;115(2):462-74. doi: 10.1378/chest.115.2.462. Chest. 1999. PMID: 10027448
-
Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.JAMA. 2016 Apr 12;315(14):1469-79. doi: 10.1001/jama.2016.2691. JAMA. 2016. PMID: 26975785
-
Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients.Acta Anaesthesiol Scand. 2011 Nov;55(10):1254-60. doi: 10.1111/j.1399-6576.2011.02535.x. Epub 2011 Sep 27. Acta Anaesthesiol Scand. 2011. PMID: 22092131
-
Clinical review: airway hygiene in the intensive care unit.Crit Care. 2008;12(2):209. doi: 10.1186/cc6830. Epub 2008 Mar 31. Crit Care. 2008. PMID: 18423061 Free PMC article. Review.
Cited by
-
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients.Antibiotics (Basel). 2024 Jun 17;13(6):564. doi: 10.3390/antibiotics13060564. Antibiotics (Basel). 2024. PMID: 38927230 Free PMC article.
-
Evaluation of nosocomial infections and risk factors in critically ill patients.Med Sci Monit. 2011 Feb 25;17(3):PH17-22. doi: 10.12659/msm.881434. Med Sci Monit. 2011. PMID: 21358613 Free PMC article.
-
PATTERN OF MULTIDRUG RESISTANT BACTERIA ASSOCIATED WITH INTENSIVE CARE UNIT INFECTIONS IN IBADAN, NIGERIA.Ann Ib Postgrad Med. 2018 Dec;16(2):162-169. Ann Ib Postgrad Med. 2018. PMID: 31217775 Free PMC article.
-
Clinical impact of carbapenems in critically ill patients with valproic acid therapy: A propensity-matched analysis.Front Neurol. 2023 Mar 9;14:1069742. doi: 10.3389/fneur.2023.1069742. eCollection 2023. Front Neurol. 2023. PMID: 37034060 Free PMC article.
-
Intensive care unit acquired infection has no impact on long-term survival or quality of life: a prospective cohort study.Crit Care. 2007;11(2):R35. doi: 10.1186/cc5718. Crit Care. 2007. PMID: 17346355 Free PMC article.
References
-
- Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin M, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in europe: results of the European Prevalence of Infection In Intensive Care (EPIC) Study. JAMA. 1995;274:639–644. doi: 10.1001/jama.274.8.639. - DOI - PubMed
-
- Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, Schaffino-Cano S, Galvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med. 1994;22:55–60. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources